Grape King Bio Ltd (1707) - Total Assets

Latest as of December 2025: NT$15.74 Billion TWD ≈ $495.84 Million USD

Based on the latest financial reports, Grape King Bio Ltd (1707) holds total assets worth NT$15.74 Billion TWD (≈ $495.84 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Grape King Bio Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Grape King Bio Ltd - Total Assets Trend (2002–2025)

This chart illustrates how Grape King Bio Ltd's total assets have evolved over time, based on quarterly financial data. Explore 1707 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Grape King Bio Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Grape King Bio Ltd's total assets of NT$15.74 Billion consist of 36.0% current assets and 64.0% non-current assets.

Asset Category	Amount (TWD)	% of Total Assets
Cash & Equivalents	NT$0.00	26.5%
Accounts Receivable	NT$368.71 Million	2.3%
Inventory	NT$979.62 Million	6.2%
Property, Plant & Equipment	NT$0.00	0.0%
Intangible Assets	NT$108.12 Million	0.7%
Goodwill	NT$0.00	0.0%

Asset Composition Trend (2002–2025)

This chart illustrates how Grape King Bio Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Grape King Bio Ltd stock valuation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Grape King Bio Ltd's current assets represent 36.0% of total assets in 2025, an increase from 0.0% in 2002.
Cash Position: Cash and equivalents constituted 26.5% of total assets in 2025, up from 2.4% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 3.0% in 2002.
Asset Diversification: The largest asset category is inventory at 6.2% of total assets.

Grape King Bio Ltd Competitors by Total Assets

Key competitors of Grape King Bio Ltd based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs585.02 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	China	CN¥10.37 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	China	CN¥7.28 Billion
Xeris Pharmaceuticals Inc NASDAQ:XERS	USA	$392.01 Million
Procter & Gamble Health Limited NSE:PGHL	India	Rs8.94 Billion

Grape King Bio Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.65	1.68	1.64
Quick Ratio	1.37	1.44	1.37
Cash Ratio	0.00	0.00	0.00
Working Capital	NT$2.24 Billion	NT$2.27 Billion	NT$1.70 Billion

Grape King Bio Ltd - Advanced Valuation Insights

This section examines the relationship between Grape King Bio Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.62
Latest Market Cap to Assets Ratio	0.03
Asset Growth Rate (YoY)	2.7%
Total Assets	NT$15.74 Billion
Market Capitalization	$462.98 Million USD

Valuation Analysis

Below Book Valuation: The market values Grape King Bio Ltd's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Grape King Bio Ltd's assets grew by 2.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Grape King Bio Ltd (2002–2025)

The table below shows the annual total assets of Grape King Bio Ltd from 2002 to 2025.

Year	Total Assets	Change
2025-12-31	NT$15.74 Billion ≈ $495.84 Million	+2.71%
2024-12-31	NT$15.32 Billion ≈ $482.78 Million	-1.21%
2023-12-31	NT$15.51 Billion ≈ $488.71 Million	+3.05%
2022-12-31	NT$15.05 Billion ≈ $474.25 Million	+7.06%
2021-12-31	NT$14.06 Billion ≈ $442.99 Million	+7.30%
2020-12-31	NT$13.10 Billion ≈ $412.85 Million	+15.36%
2019-12-31	NT$11.36 Billion ≈ $357.87 Million	+6.68%
2018-12-31	NT$10.65 Billion ≈ $335.47 Million	+7.65%
2017-12-31	NT$9.89 Billion ≈ $311.64 Million	+3.58%
2016-12-31	NT$9.55 Billion ≈ $300.87 Million	+10.88%
2015-12-31	NT$8.61 Billion ≈ $271.34 Million	+60.41%
2014-12-31	NT$5.37 Billion ≈ $169.15 Million	+15.99%
2013-12-31	NT$4.63 Billion ≈ $145.83 Million	+19.66%
2012-12-31	NT$3.87 Billion ≈ $121.87 Million	+11.94%
2011-12-31	NT$3.46 Billion ≈ $108.87 Million	+7.95%
2010-12-31	NT$3.20 Billion ≈ $100.86 Million	-0.12%
2009-12-31	NT$3.21 Billion ≈ $100.98 Million	+23.95%
2008-12-31	NT$2.59 Billion ≈ $81.47 Million	+2.36%
2007-12-31	NT$2.53 Billion ≈ $79.59 Million	+1.67%
2006-12-31	NT$2.48 Billion ≈ $78.28 Million	+4.91%
2005-12-31	NT$2.37 Billion ≈ $74.61 Million	-3.53%
2004-12-31	NT$2.45 Billion ≈ $77.34 Million	+6.26%
2003-12-31	NT$2.31 Billion ≈ $72.78 Million	-6.94%
2002-12-31	NT$2.48 Billion ≈ $78.21 Million	--

About Grape King Bio Ltd

TW:1707 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$462.98 Million

NT$14.70 Billion TWD

Market Cap Rank

#12856 Global

#496 in Taiwan

Share Price

NT$99.20

Change (1 day)

-3.69%

52-Week Range

NT$99.20 - NT$136.00

All Time High

NT$227.99